Pfizer Drops Immune Response's HIV Drug
Immune Response (IMNR ) says Pfizer's Agouron Pharma unit has terminated further development of Remune, the company's investigational HIV drug. Immune Response shares were trading sharply lower.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.